Creative Medical Technology (CELZ) Competitors $3.21 +0.03 (+0.94%) Closing price 03:59 PM EasternExtended Trading$3.18 -0.03 (-0.93%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. RNXT, ITRM, CLSD, DYAI, MAAQ, CASI, KZR, AKTX, DARE, and TRIBShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include RenovoRx (RNXT), Iterum Therapeutics (ITRM), Clearside Biomedical (CLSD), Dyadic International (DYAI), Mana Capital Acquisition (MAAQ), CASI Pharmaceuticals (CASI), Kezar Life Sciences (KZR), Akari Therapeutics (AKTX), Dare Bioscience (DARE), and Trinity Biotech (TRIB). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors RenovoRx Iterum Therapeutics Clearside Biomedical Dyadic International Mana Capital Acquisition CASI Pharmaceuticals Kezar Life Sciences Akari Therapeutics Dare Bioscience Trinity Biotech Creative Medical Technology (NASDAQ:CELZ) and RenovoRx (NASDAQ:RNXT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations. Which has more volatility & risk, CELZ or RNXT? Creative Medical Technology has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Comparatively, RenovoRx has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Do analysts prefer CELZ or RNXT? RenovoRx has a consensus price target of $7.50, suggesting a potential upside of 594.44%. Given RenovoRx's stronger consensus rating and higher probable upside, analysts clearly believe RenovoRx is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creative Medical Technology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00RenovoRx 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in CELZ or RNXT? 1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 3.1% of RenovoRx shares are held by institutional investors. 1.8% of Creative Medical Technology shares are held by insiders. Comparatively, 9.1% of RenovoRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer CELZ or RNXT? In the previous week, RenovoRx had 2 more articles in the media than Creative Medical Technology. MarketBeat recorded 2 mentions for RenovoRx and 0 mentions for Creative Medical Technology. Creative Medical Technology's average media sentiment score of 1.91 beat RenovoRx's score of 1.22 indicating that Creative Medical Technology is being referred to more favorably in the media. Company Overall Sentiment Creative Medical Technology Very Positive RenovoRx Positive Which has stronger earnings and valuation, CELZ or RNXT? Creative Medical Technology has higher earnings, but lower revenue than RenovoRx. RenovoRx is trading at a lower price-to-earnings ratio than Creative Medical Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$10K828.18-$5.49M-$3.18-1.01RenovoRx$662K59.79-$8.81M-$0.38-2.84 Is CELZ or RNXT more profitable? Creative Medical Technology's return on equity of -82.99% beat RenovoRx's return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -82.99% -79.49% RenovoRx N/A -120.68%-89.23% SummaryRenovoRx beats Creative Medical Technology on 8 of the 14 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.21M$3.10B$5.69B$9.68BDividend YieldN/A2.28%6.66%4.54%P/E RatioN/A20.9982.6526.40Price / Sales828.18207.75454.15178.36Price / CashN/A43.5325.7028.92Price / Book1.219.8811.246.06Net Income-$5.49M-$53.38M$3.28B$266.05M7 Day Performance1.58%-0.14%0.15%-0.07%1 Month Performance11.85%9.18%8.34%5.83%1 Year Performance-7.76%7.53%54.21%17.88% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology0.6013 of 5 stars$3.21+0.9%N/A-8.6%$8.21M$10K0.005Positive NewsRNXTRenovoRx2.6521 of 5 stars$0.92+2.8%$7.25+684.8%-5.9%$32.92M$662K-2.436Positive NewsShort Interest ↑ITRMIterum Therapeutics3.1666 of 5 stars$0.68-5.2%$9.00+1,217.1%-42.6%$32.20MN/A-0.8010Positive NewsShort Interest ↓CLSDClearside Biomedical2.9485 of 5 stars$0.40-1.9%$4.20+962.5%-63.6%$31.62M$1.66M-1.0730Positive NewsGap DownDYAIDyadic International3.4311 of 5 stars$0.90+4.0%$6.00+563.2%-31.2%$31.48M$3.49M-4.767Positive NewsShort Interest ↓MAAQMana Capital AcquisitionN/A$3.68+1.1%N/A+916.0%$29.90MN/A0.001CASICASI Pharmaceuticals3.6464 of 5 stars$2.29-5.8%$4.00+74.7%-64.9%$29.89M$31.37M-0.90180Earnings ReportShort Interest ↑KZRKezar Life Sciences3.5849 of 5 stars$3.96-1.0%$9.00+127.3%-34.2%$29.29M$7M-0.4160AKTXAkari Therapeutics3.4294 of 5 stars$0.86-2.8%$5.00+481.4%-80.2%$28.48MN/A0.009Positive NewsShort Interest ↑DAREDare Bioscience2.0074 of 5 stars$2.04-1.9%$12.00+488.2%-43.6%$28.04M$10K-0.9530TRIBTrinity Biotech0.5447 of 5 stars$1.47-5.2%N/A-85.3%$27.98M$61.56M-0.50480Short Interest ↑ Related Companies and Tools Related Companies RenovoRx Alternatives Iterum Therapeutics Alternatives Clearside Biomedical Alternatives Dyadic International Alternatives Mana Capital Acquisition Alternatives CASI Pharmaceuticals Alternatives Kezar Life Sciences Alternatives Akari Therapeutics Alternatives Dare Bioscience Alternatives Trinity Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELZ Stock Alerts